advertisement
 

  Back to Polls Poll Results

Poll Results

 

Which insulins do you or your child use?

 
 

Vote for all that apply

 
 

Short acting insulins

 
     

NovoLog/Novorapid

 
 

28%

 

  246

 
     

Humalog

 
 

20%

 

  174

 
     

Regular/Actrapid/Velosulin

 
 

1%

 

  13

 
     

Apidra

 
 

1%

 

  2

 
     

Other short acting insulin

 
 

0%

 

   0

 
 

Long acting insulins

 
     

Lantus

 
 

32%

 

  277

 
     

Levemir

 
 

2%

 

  23

 
     

NPH/Isophane/Insulatard

 
 

8%

 

  68

 
     

Lente

 
 

1%

 

  3

 
     

Ultralente

 
 

1%

 

  1

 
     

Other long acting insulin

 
 

1%

 

  13

 
 

Other

 
     

Premixed (70/30, etc.)

 
 

1%

 

  15

 
     

Other insulin

 
 

1%

 

  4

 
     

Don't use insulin

 
 

1%

 

  10

 


Total votes: 849

 

Which insulins do you or your child use?

Poll dates: January 15 - 22, 2006
Total Votes: 849

Insulin users today have a great variety of products from which to choose. In the past few years, two fast-acting analogs (NovoLog and Humalog) and one long-acting analog (Lantus) have been introduced and have changed the way many people use insulin. The use of Regular insulin among our readers has dropped off to just one percent. NPH use has dropped too, from 32% in 2000 to just 8% in 2006.

This table shows readers' answers to this survey over the past years:

  Answer     Jan 2006     Jan 2005     Jan 2004     Jan 2003     Jan 2002     Mar 2000  
Short acting insulins
NovoLog 28% 27% 26% 12% 3% --
Humalog 20% 22% 26% 34% 37% 35%
Regular 1% 1% 2% 3% 4% 12%
Apidra 1% 1% -- -- -- --
Long acting insulins
Lantus 32% 27% 21% 17% 11% --
Levemir 2% 1% -- -- -- --
NPH 8% 14% 16% 22% 28% 32%
Lente 1% 1% 1% 1% 3% 4%
Ultralente 1% 1% 1% 2% 5% 7%
Other
Premixed 1% 1% 1% 2% 2% 5%
Other insulin 1% 1% 1% 2% 2% 2%
Percentages based on use compared with all responses

Looking at answers in the short-acting and long-acting insulins shows a dramatic change since 2000. The following graphs illustrate the rapid increase in use of insulin analogs and the concurrent decline in the use of Regular and NPH.

Rapid Acting Insulin Use

The rise in the use of NovoLog has been particularly significant since it was introduced in 2002. Among users of rapid-acting insulin, NovoLog is used by more than half of our visitors (57%, up from 53% in 2005), while use of Humalog continues to decline (now at 40%, down from 43% in 2005). Apidra, new to the US market, has a few users, accounting for just 0.5% of rapid acting insulin uses. The use of Regular has declined to one percent of CWD visitors.

Graph. Click for larger view.
Data within rapid-acting insulin only

Graph. Click for larger view.
Data among all responses

Long Acting Insulin Use

As of January 2006, more CWD visitors report using Lantus than any other insulin. This year, almost three-fourths (74%) of people who use long acting insulin report using Lantus, up from 62% last year. The use of NPH continues to decline and and now stands at just 18%, down almost half from last year's 32%. Few people use Lente and Ultralente. Levemir, new in 2005, is used by 6%, up from just 1% last year. Given the clinical benefits of using Lantus or Levemir over NPH, it's no surprise to see the rapid decline in use of NPH. (See our page about Care Suggestions for citations to studies about NPH.)

Graph. Click for larger view.
Data within long-acting insulin only

Graph. Click for larger view.
Data among all responses

[Download an Excel spreadsheet with the data and graphs from this poll]

[Return to the current poll]



                 
  Home Return to Top

Last Updated: Sunday January 22, 2006 13:48:00
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.